食品伙伴網(wǎng)訊 據(jù)美國(guó)聯(lián)邦公報(bào)消息,美國(guó)FDA將于9月14日發(fā)布一項(xiàng)公告,撤銷一款獸藥(含金霉素、普魯卡因青霉素、磺胺二甲嘧啶)的許可。
該款獸藥用于促進(jìn)豬生長(zhǎng)以及飼料在豬體內(nèi)的轉(zhuǎn)化率。生產(chǎn)廠商表示,該款獸藥不再生產(chǎn),因此美國(guó)FDA撤銷該款獸藥的許可申請(qǐng)。
部分原文報(bào)道如下:
The Food and Drug Administration (FDA) is withdrawing approval of those parts of a new animal drug application (NADA) for a 3-way, fixed-ratio, combination drug Type A medicated article that pertain to use of the procaine penicillin component for production indications in swine. This action is being taken at the sponsor's request because the 3-way Type A medicated article is no longer manufactured.
原文鏈接:https://www.federalregister.gov/documents/2016/09/14/2016-21984/new-animal-drugs-chlortetracycline-procaine-penicillin-and-sulfamethazine-withdrawal-of-approval